Gastric MALT lymphoma: epidemiology and high adenocarcinoma risk in a nation-wide study

Eur J Cancer. 2008 Nov;44(16):2470-6. doi: 10.1016/j.ejca.2008.07.005. Epub 2008 Aug 15.

Abstract

Background: Gastric marginal zone non-Hodgkin lymphomas MALT type (gMALT) and gastric adenocarcinomas (GC) are long-term complications of chronic Helicobacter pylori gastritis, however, the incidence of gMALT and the GC risk in these patients is unclear.

Objective: To evaluate epidemiological time trends of gMALT in the Netherlands and to estimate GC risk.

Methods: Patients with a first diagnosis of gMALT between 1991 and 2006 were identified in the Dutch nation-wide histopathology registry (PALGA). Age-standardised incidence rates were calculated. The incidences of GC in patients with gMALT and in the Dutch population were compared. Relative risks were calculated by a Poisson Model.

Results: In total, 1419 patients were newly diagnosed with gMALT, compatible with an incidence of 0.41/100,000/year. GC was diagnosed in 34 (2.4%) patients of the cohort. Patients with gMALT had a sixfold increased risk for GC in comparison with the general population (p<0.001). This risk was 16.6 times higher in gMALT patients aged between 45 and 59 years than in the Dutch population (p<0.001).

Conclusions: GC risk in patients with gMALT is six times higher than in the Dutch population and warrants accurate re-evaluation after diagnosis and treatment for gMALT.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / epidemiology*
  • Adolescent
  • Adult
  • Age Distribution
  • Age of Onset
  • Aged
  • Aged, 80 and over
  • Female
  • Humans
  • Lymphoma, B-Cell, Marginal Zone / epidemiology*
  • Male
  • Middle Aged
  • Netherlands / epidemiology
  • Risk Assessment
  • Risk Factors
  • Stomach Neoplasms / epidemiology*
  • Young Adult